Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

De-escalation of anti-CD20 monoclonal antibody (Rituximab) protocols in Pemphigus Vulgaris ��� a systematic review

Autor: McClatchy, Jessica, Yap, Tami, Koo, Kendrick, Kern, Johannes S, Scardamaglia, Laura

Introduction: This review assesses current evidence supporting dose de-escalated rituximab therapy in pemphigus vulgaris, compared to standard protocols. Primary outcome measures were remission and relapse rates. Adverse effects, cumulative steroid d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84cfc2cf3ded5ed4eb0716b2a6408eb3

De-escalation of anti-CD20 monoclonal antibody (Rituximab) protocols in Pemphigus Vulgaris - a systematic review.

Autor: McClatchy J; Dermatology Department, The Royal Melbourne Hospital, Melbourne, Australia.; Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia., Yap T; Dermatology Department, The Royal Melbourne Hospital, Melbourne, Australia.; Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia.; Melbourne Dental School, The University of Melbourne, Melbourne, Australia., Koo K; Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia.; Melbourne Dental School, The University of Melbourne, Melbourne, Australia., Kern JS; Dermatology Department, The Royal Melbourne Hospital, Melbourne, Australia.; Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia., Scardamaglia L; Dermatology Department, The Royal Melbourne Hospital, Melbourne, Australia.; Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia.

Publikováno v: Expert opinion on biological therapy [Expert Opin Biol Ther] 2021 Dec; Vol. 21 (12), pp. 1591-1601. Date of Electronic Publication: 2021 Jun 11.